Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
557
-
Total 13F shares, excl. options
-
45.8M
-
Shares change
-
+674K
-
Total reported value, excl. options
-
$14.6B
-
Value change
-
+$331M
-
Put/Call ratio
-
1.11
-
Number of buys
-
295
-
Number of sells
-
-244
-
Price
-
$318.55
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2024
643 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q2 2024.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 557 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.8M shares
.
Largest 10 shareholders include BlackRock Inc. (5.47M shares), VANGUARD GROUP INC (4.42M shares), WELLINGTON MANAGEMENT GROUP LLP (3.29M shares), Avoro Capital Advisors LLC (2.86M shares), STATE STREET CORP (2.29M shares), RENAISSANCE TECHNOLOGIES LLC (2.17M shares), CITIGROUP INC (1.63M shares), GEODE CAPITAL MANAGEMENT, LLC (1.05M shares), LSV ASSET MANAGEMENT (966K shares), and MORGAN STANLEY (807K shares).
This table shows the top 557 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.